In recent years, inflammatory mechanisms have been increasingly appreciated
as important steps in the pathology of Alzheimer's disease (AD), There are
two pathological defects in AD: chronic inflammation and impaired clearanc
e of amyloid beta-peptide (A beta), In the periphery, estrogen both increas
es macrophage phagocytosis and has antiinflammatory effects. If estrogen ha
d a similar effect in the CNS, it could reverse inflammatory defects in AD.
Although microglia are a key component of the immune system and help clear
A beta deposits in the AD brain, little is known about the effects of estr
ogen on CNS microglia. Therefore, we sought to determine the relationship b
etween estrogen treatment and internalization of A beta by microglia by qua
ntifying the internalization of aggregated A beta by human cortical microgl
ia. A beta uptake was found to be dose- and time-dependent in cultured micr
oglia. Increased A beta uptake was observed at 1.5 and 24 h after addition
of aggregated A beta (50, 100, or 1,000 nM A beta), and this uptake was enh
anced by pretreatment with estrogen. The expression of estrogen receptor (E
R) beta (ER-beta) was also up-regulated by estrogen treatment. Cells cotrea
ted with ICI 182,780, an ER antagonist, showed significantly reduced intern
alization of A beta in cultured microglia, These results indicate that micr
oglia express an ER-beta but that the effect of estrogen on enhancing clear
ance of A beta may be related to the receptor-independent action of estroge
n or to nonclassical ER effects of estrogen, Thus, stimulation of the ER mi
ght contribute to the therapeutic action of estrogen in the treatment of AD
.